BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38644411)

  • 1. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
    Zhao M; Yu Y; Song Z
    Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
    Xia F; Yu Z; Deng A; Gao G
    Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
    Zhang F; Deng Y; Wang D; Wang S
    Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
    Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
    Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
    Pan H; Lu L; Cui J; Yang Y; Wang Z; Fan X
    Aging (Albany NY); 2020 Jan; 12(2):1446-1464. PubMed ID: 31954372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
    Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
    Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
    Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
    Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
    Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
    Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
    Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
    Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
    Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
    Yingjuan W; Li Z; Wei C; Xiaoyuan W
    Medicine (Baltimore); 2021 May; 100(21):e26017. PubMed ID: 34032721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.